Preliminary safety data from phase 2 study.
Annual report from Public Health Scotland.
High infiltration is associated with improved survival after chemoradiation.
Multinational observational SUCCOR study.
ACS cites low efficacy and low cancer prevention potential of vaccination in older adults.
ACS cites low efficacy and low cancer prevention potential of vaccination in older adults.
Findings from an online survey.
Compared with women who never smoked, current smokers were 45 per cent less likely to get screened for breast cancer.
Phase 2 trial shows acceptable toxicity.
Overscreening particularly high for women living in metropolitan areas.
Screening outside the recommended age range may cause more harm than good.
Recommends screening initiation at 25 years in asymptomatic individuals.
Hybrid model shows high sensitivity.
Recommendation outlines indications, best practices in the postoperative and definitive settings.
HPV clearance at 6 weeks can aid in further treatment decision-making.
This is the first study assessing the effect of SMS on cervical screening rates.
The deadline for submission of comments on the draft recommendations is fast approaching.
